Home / Articles / Notre Dame Football / Notre Dame Football 2014 – Playoff Prognosis

Notre Dame Football 2014 – Playoff Prognosis

It wasn’t too long ago Notre Dame was playing in the National Championship. What will it take for Brian Kelly and company to make the inaugural Playoff? Campus Insiders’ Jordan Cornette and Doug Chapman break down what it will take for the Irish to return to college football’s elite


  1. Toulmin H. Brown

    “Play both quarterbacks initially and it will become clear within two to three weeks who is better. One does this to increase the probability of winning huge gridiron fights as the season unfolds. FSU, Stanford, MSU, Michigan and Louisville all seem to fit this scenario.”

    I like the defensive coordinator on paper. Can he produce at Notre Dame?

  2. give the ball to Bryant. A lot.

  3. Have to be fair with the new defensive coordinator. A lot of real strength
    lost. Like his new style though. Playoffs next year. Count on it.

  4. It’s a tough slate for sure, no MSU helps though. This will be an offensive driven team this year with the defense struggling at times but making more big plays with the aggressive style Van Gorder brings. If they take it game by game like in 2012 they could/should win at least 10, possibly 11. FSU is a loss for sure. It will be a good season but still a year away.

  5. I was wondering if you guys could help me out?

    There are 3 very high risk stocks that I have been teetering back and forth on.

    Perhaps you could use your special powers and tell me whether I should buy or pass??? Maybe?

    1. Energy Recovery, Inc. (ERII): Engages in the development, manufacture, and sale of energy recovery devices and pumps primarily for use in seawater and brackish water desalination worldwide. Market cap at $242.5M, most recent closing price at $4.75.

    2. Sangamo Biosciences Inc. (SGMO): Engages in the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Market cap at $1.21B, most recent closing price at $19.61.

    3. Gilead Sciences Inc. (GILD): Engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Market cap at $127.11B, most recent closing price at $82.87.

    Thanks fella’s!
    You guys are the Greatest!

  6. BVG’s da man.

Leave a Reply

Your email address will not be published. Required fields are marked *